Prescription Drug Affordability Board (PDAB)

About the PDAB

Senate Bill 844 created the Prescription Drug Affordability Board (PDAB) to evaluate the cost of prescription drugs and determine whether they present an affordability challenge for consumers and health systems in Oregon. PDAB’s review will inform rulemaking criteria for evaluating drugs, including health inequities in diverse communities, the number of Oregon residents prescribed the drug, the price of the drug in Oregon, and other criteria. The board has studied the prescription drug distribution and payment system in Oregon and the generic drug market and provided recommendations to the Legislature. Read the 2022 board reports. The board's statutory authority is ORS 646A.693-697.

Visit the PDAB rulemaking page